Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice
- PMID: 12594538
- DOI: 10.1007/s00394-003-0396-4
Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice
Abstract
Background & aims: Punicalagin is an antioxidant ellagitannin of pomegranate juice. This compound is responsible for the high antioxidant activity of this juice. Nothing is known about the bioavailability and metabolism of punicalagin or other food ellagitannins. The present work aims to evaluate the bioavailability and metabolism of punicalagin in the rat as an animal model.
Design: Two groups of rats were studied. One fed with standard rat diet (n = 5) and another with the same diet plus 6 % punicalagin (n = 5). Samples of urine and faeces were taken during 37 days and plasma every week. The different metabolites were analysed by HPLC-MS-MS.
Results: The daily intake of punicalagin ranged from 0.6 to 1.2 g. Values around 3-6 % the ingested punicalagin were excreted as identified metabolites in faeces and urine. In faeces, punicalagin is transformed to hydrolysis products and partly metabolites by the rat microflora to 6H-dibenzo[b,d]pyran-6-one derivatives. In plasma, punicalagin was detected at concentrations around 30 microg/mL, and glucuronides of methyl ether derivatives of ellagic acid were also detected. 6H-Dibenzo[b,d]pyran-6-one derivatives were also detected especially during the last few weeks of the experiment. In urine, the main metabolites observed were the 6H-dibenzo[b,d]pyran-6-one derivatives, as aglycones or glucuronides.
Conclusion: As only 3-6 % of the ingested punicalagin was detected as such or as metabolites in urine and faeces, the majority of this ellagitannin has to be converted to undetectable metabolites (i. e. CO(2)) or accumulated in non-analysed tissues, however with only traces of punicalagin metabolites being detected in liver or kidney. This is the first report on the absorption of an ellagitannin and its presence in plasma. In addition, the transformation of ellagic acid derivatives to 6H-dibenzo[b,d]pyran-6-one derivatives in the rat is also confirmed.
Similar articles
-
Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic.J Agric Food Chem. 2003 May 21;51(11):3493-501. doi: 10.1021/jf020842c. J Agric Food Chem. 2003. PMID: 12744688
-
The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.Eur J Nutr. 2004 Aug;43(4):205-20. doi: 10.1007/s00394-004-0461-7. Epub 2004 Jan 6. Eur J Nutr. 2004. PMID: 15309440
-
Identification of urolithin a as a metabolite produced by human colon microflora from ellagic acid and related compounds.J Agric Food Chem. 2005 Jul 13;53(14):5571-6. doi: 10.1021/jf050384i. J Agric Food Chem. 2005. PMID: 15998116
-
Multitargeted therapy of cancer by ellagitannins.Cancer Lett. 2008 Oct 8;269(2):262-8. doi: 10.1016/j.canlet.2008.03.043. Epub 2008 May 12. Cancer Lett. 2008. PMID: 18468784 Review.
-
Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.Int J Toxicol. 2007;26 Suppl 1:3-106. doi: 10.1080/10915810601163939. Int J Toxicol. 2007. PMID: 17365137 Review.
Cited by
-
Precision Nutrition to Activate Thermogenesis as a Complementary Approach to Target Obesity and Associated-Metabolic-Disorders.Cancers (Basel). 2021 Feb 18;13(4):866. doi: 10.3390/cancers13040866. Cancers (Basel). 2021. PMID: 33670730 Free PMC article. Review.
-
Punicalagin attenuates osteoclast differentiation by impairing NFATc1 expression and blocking Akt- and JNK-dependent pathways.Mol Cell Biochem. 2015 Sep;407(1-2):161-72. doi: 10.1007/s11010-015-2466-3. Epub 2015 Jun 6. Mol Cell Biochem. 2015. PMID: 26048715
-
A Synergistic Combination of DHA, Luteolin, and Urolithin A Against Alzheimer's Disease.Front Aging Neurosci. 2022 Feb 16;14:780602. doi: 10.3389/fnagi.2022.780602. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35250535 Free PMC article.
-
Pomegranate-specific natural compounds as onco-preventive and onco-therapeutic compounds: Comparison with conventional drugs acting on the same molecular mechanisms.Heliyon. 2023 Jul 8;9(7):e18090. doi: 10.1016/j.heliyon.2023.e18090. eCollection 2023 Jul. Heliyon. 2023. PMID: 37519687 Free PMC article. Review.
-
Urolithin a alleviates oxidative stress-induced senescence in nucleus pulposus-derived mesenchymal stem cells through SIRT1/PGC-1α pathway.World J Stem Cells. 2021 Dec 26;13(12):1928-1946. doi: 10.4252/wjsc.v13.i12.1928. World J Stem Cells. 2021. PMID: 35069991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials